| Literature DB >> 25608936 |
Michael Shelanski1, William Shin, Soline Aubry, Peter Sims, Mariano J Alvarez, Andrea Califano.
Abstract
In the articles included in this volume, one feels a strong frustration among the writers with the slow course of therapeutics development for Alzheimer's disease and with the clinical failure of targeted therapeutic agents despite substantial progress in our understanding of the biology and biochemistry of the disease.Entities:
Mesh:
Year: 2015 PMID: 25608936 PMCID: PMC4322083 DOI: 10.1007/s13311-014-0335-5
Source DB: PubMed Journal: Neurotherapeutics ISSN: 1878-7479 Impact factor: 7.620